You are viewing: China Organ Preservation Market analysis
Part of: Organ Preservation Market (Global)

The China Organ Preservation Market was valued at $24.33 Million in 2025 and projected to reach to $35.7 Million by 2030, representing a compound annual growth rate of 8.0%. China's organ preservation market is positioned for sustained expansion driven by government commitment to transplantation infrastructure development and rising organ donation rates.

China Organ Preservation Market Trends and Insights

  • This 8.0% compound annual growth rate reflects China's increasing investment in transplantation infrastructure and advanced preservation technologies.
  • China's rising organ donation rates and government initiatives to improve transplant accessibility are driving demand for sophisticated preservation solutions across major medical centers. The organ preservation sector in China is benefiting from technological advancements in hypothermic and normothermic perfusion systems.
  • China's expanding healthcare expenditure and regulatory support for organ transplantation programs are accelerating market adoption.
  • Between 2025 and 2030, China is expected to see significant growth in both static cold storage and dynamic preservation device segments, supported by improved clinical outcomes and surgeon training programs. China's position as a major transplant hub in Asia Pacific underscores the strategic importance of organ preservation innovation.
  • The market's trajectory reflects China's commitment to reducing organ shortage challenges and enhancing transplant success rates through preservation technology investment..

Key Market Statistics

  • CAGR (2025-2030) 8.0% CAGR
  • Market Size, 2025 ~USD 24.33 Million
  • Forecast, 2030 ~USD 35.7 Million
  • Country China

China Organ Preservation Market Overview

Market Valuation Growth :

China's organ preservation market is valued at $24.33 million in 2025, with projections reaching $35.7 million by 2030, representing an 8% CAGR—outpacing the global average of 6.8%.

Government Support & Infrastructure :

China's government initiatives to improve transplant accessibility and expand transplantation infrastructure are driving significant investment in advanced organ preservation technologies across major medical centers.

Rising Organ Donation Rates :

Increasing organ donation rates in China, supported by regulatory reforms and public awareness campaigns, are creating sustained demand for sophisticated preservation solutions and cold chain management systems.

Technology Adoption :

Chinese hospitals and transplant centers are rapidly adopting advanced preservation technologies, including normothermic perfusion systems and improved storage solutions, to enhance transplant outcomes and reduce organ wastage.

China Organ Preservation Market Dynamics

  • The 8% CAGR reflects increasing adoption of advanced preservation technologies among Chinese hospitals and transplant centers, supported by regulatory reforms that enhance transplant accessibility.
  • Investment in cold chain management and perfusion systems is accelerating as medical institutions prioritize improved transplant outcomes.
  • The market is expected to benefit from continued government initiatives, growing healthcare expenditure, and increasing awareness of organ donation importance among the Chinese population..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's organ preservation market grows at 8.0% CAGR from 2025 to 2030, outpacing global growth of 6.8%.
    • Market size in China expands from $24.33 million in 2025 to $35.7 million by 2030, driven by transplant infrastructure investment.
    • China's government support for organ donation programs and transplant accessibility initiatives accelerate preservation technology adoption.
    • Dynamic perfusion systems and advanced hypothermic preservation solutions gain traction in China's major transplant centers.

    Organ Preservation Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment PERFADEX (Solution)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.8% from 2025 to 2030
    Largest Segment ORGAN TRANSPLANT CENTERS (End User)
    Market Size Base Year (Billions) ~USD 0.22 (2025)
    Revenue Forecast (Billions) ~USD 0.3 (2030)
    Segments Covered Solution, Technique, Organ Type, End User

    China Organ Preservation Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Solution

    • Custodiol Htk
    • Other Solutions
    • Perfadex
    • University Of Wisconsin Solution

    By Technique

    • Hypothermic Machine Perfusion
    • Normothermic Machine Perfusion
    • Static Cold Storage

    By Organ Type

    • Heart
    • Kidneys
    • Liver
    • Lungs
    • Other Organs

    By End User

    • Hospitals
    • Organ Transplant Centers
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : Manufacturers of organ preservation equipment and perfusion systems need China-specific market data to develop localized product strategies, identify distribution partners, and capitalize on the 8% growth opportunity.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market sizing, growth forecasts, and regulatory insights for China to evaluate acquisition targets, fund allocation decisions, and portfolio companies in the transplantation sector.
    • Hospital & Transplant Center Operators : Chinese hospital networks and transplant centers need competitive benchmarking data and technology adoption trends to optimize procurement decisions, upgrade preservation infrastructure, and improve transplant outcomes.
    • Pharmaceutical & Biotech Companies : Companies developing organ preservation solutions, perfusion fluids, and preservation additives require China market intelligence to guide R&D investments, clinical trial planning, and market entry strategies.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts covering China's healthcare sector need granular market data and forecasts to support client advisory work, competitive intelligence, and strategic planning engagements.

    Key Companies in the China Organ Preservation Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyStatic Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care,
    XVIVO PERFUSION ABSwedenPublic CompanyPerfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions,
    TRANSMEDICS, INC.United StatesPublic CompanyOCS Heart,OCS Lung,OCS Liver,
    BIOLIFE SOLUTIONS, INC.United StatesPublic CompanyHypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport),
    SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.ChinaPrivate CompanyUW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms),

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.

    XVIVO PERFUSION AB

    XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.

    TRANSMEDICS, INC.

    TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.

    BIOLIFE SOLUTIONS, INC.

    BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.

    SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.

    Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.

    Reasons to Buy this Report

    • Market Size & Growth Trajectory : Gain precise valuation data for China's organ preservation market ($24.33M in 2025) with 8% CAGR forecasts through 2030, enabling accurate investment and expansion planning in this high-growth segment.
    • Government Policy Insights : Understand China-specific regulatory frameworks, government initiatives, and transplantation infrastructure investments that are reshaping the competitive landscape and creating market opportunities.
    • Technology Adoption Trends : Identify which advanced preservation technologies (perfusion systems, storage solutions, cold chain management) are gaining traction among Chinese hospitals and transplant centers for strategic product positioning.
    • Competitive Landscape Analysis : Access detailed insights into local and international competitors operating in China's organ preservation market, including market share, partnerships, and strategic positioning specific to the Chinese healthcare ecosystem.
    • Demand Drivers & Opportunities : Leverage data on rising organ donation rates, increasing healthcare expenditure, and hospital modernization trends to identify high-potential customer segments and geographic expansion opportunities within China.

    Frequently asked questions

    What is the current size of China's organ preservation market?

    China's organ preservation market is valued at $24.33 million in 2025 and is projected to reach $35.7 million by 2030.

    What is the growth rate of China's organ preservation market?

    China's organ preservation market is growing at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2030.

    What factors are driving growth in China's organ preservation market?

    Growth in China's organ preservation market is driven by increased government support for organ donation programs, expanding healthcare expenditure, rising transplant volumes, and adoption of advanced preservation technologies.

    Which preservation technologies are gaining adoption in China?

    Dynamic perfusion systems and advanced hypothermic preservation solutions are gaining significant traction in China's major transplant centers and hospitals.

    How does China's market growth compare to global trends?

    China's organ preservation market grows at 8.0% CAGR, exceeding the global CAGR of 6.8%, reflecting stronger regional demand and investment in transplant infrastructure.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.

    This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.

    Primary Research

    Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.

    The following is a breakdown of the primary respondents:

    Organ Preservation Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the organ preservation market includes the following details.

    The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach

    Organ Preservation Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.

    Market Definition

    Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.

    Stakeholders

    • Association of Organ Procurement Organizations (AOPO)
    • American Transplant Congress (ATC)
    • United Network for Organ Sharing (UNOS)
    • Network & Alliance of Transplant Coordinators (NATCO)
    • Consortium for Organ Preservation in Europe (COPE)
    • European Society for Organ Transplantation (ESOT)
    • Asian Society of Transplantation (AST)
    • National Health Service (UK NHS)
    • International Registry on Organ Donation and Transplantation (IRODaT)
    • Global Observatory on Donation and Transplants (GODT)
    • National Institutes of Health (NIH)
    • World Health Organization (WHO)
    • Organisation for Economic Co-operation and Development (OECD)
    • Centers for Disease Control and Prevention (CDC)
    • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
    • White Papers, Journals/Magazines, and News Articles

    Report Objectives

    • To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
    • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
    • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
    • To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering

     

    Get the Full Organ Preservation Market Report

    Full forecast, segment splits, and company analysis for all Organ Preservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status